Free Trial
NASDAQ:INVA

Innoviva (INVA) Stock Price, News & Analysis

Innoviva logo
$19.17 +0.11 (+0.56%)
As of 02:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Innoviva Stock (NASDAQ:INVA)

Key Stats

Today's Range
$18.92
$19.40
50-Day Range
$18.01
$21.80
52-Week Range
$16.48
$22.00
Volume
251,052 shs
Average Volume
699,187 shs
Market Capitalization
$1.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.00
Consensus Rating
Buy

Company Overview

Innoviva Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

INVA MarketRank™: 

Innoviva scored higher than 77% of companies evaluated by MarketBeat, and ranked 228th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Innoviva has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Innoviva has received no research coverage in the past 90 days.

  • Read more about Innoviva's stock forecast and price target.
  • Earnings Growth

    Earnings for Innoviva are expected to grow by 369.70% in the coming year, from $0.33 to $1.55 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Innoviva is -18.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Innoviva is -18.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Innoviva has a P/B Ratio of 1.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Innoviva's valuation and earnings.
  • Percentage of Shares Shorted

    15.56% of the float of Innoviva has been sold short.
  • Short Interest Ratio / Days to Cover

    Innoviva has a short interest ratio ("days to cover") of 11.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Innoviva has recently increased by 3.99%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Innoviva does not currently pay a dividend.

  • Dividend Growth

    Innoviva does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.56% of the float of Innoviva has been sold short.
  • Short Interest Ratio / Days to Cover

    Innoviva has a short interest ratio ("days to cover") of 11.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Innoviva has recently increased by 3.99%, indicating that investor sentiment is decreasing.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Innoviva this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for INVA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Innoviva insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.25% of the stock of Innoviva is held by insiders.

  • Percentage Held by Institutions

    99.12% of the stock of Innoviva is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Innoviva's insider trading history.
Receive INVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innoviva and its competitors with MarketBeat's FREE daily newsletter.

INVA Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

INVA Stock Analysis - Frequently Asked Questions

Innoviva's stock was trading at $17.35 at the beginning of 2025. Since then, INVA shares have increased by 10.5% and is now trading at $19.1660.

Innoviva, Inc. (NASDAQ:INVA) announced its quarterly earnings results on Wednesday, May, 7th. The biotechnology company reported $0.25 EPS for the quarter. The biotechnology company had revenue of $88.63 million for the quarter. Innoviva had a negative net margin of 16.15% and a positive trailing twelve-month return on equity of 15.77%.

Innoviva's top institutional investors include Parallel Advisors LLC.
View institutional ownership trends
.

Shares of INVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Innoviva investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
5/07/2025
Today
7/09/2025
Next Earnings (Estimated)
7/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Large Cap Pharma
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:INVA
Previous Symbol
NASDAQ:THRX
CIK
1080014
Employees
100
Year Founded
1996

Price Target and Rating

High Price Target
$55.00
Low Price Target
$55.00
Potential Upside/Downside
+188.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
57.76
P/E Growth
N/A
Net Income
$23.39 million
Pretax Margin
-12.53%

Debt

Sales & Book Value

Annual Sales
$358.71 million
Cash Flow
$3.45 per share
Price / Cash Flow
5.52
Book Value
$11.03 per share
Price / Book
1.73

Miscellaneous

Free Float
61,363,000
Market Cap
$1.20 billion
Optionable
Optionable
Beta
0.37

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:INVA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners